This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koprivnjak, T.
Right arrow Articles by Weiss, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koprivnjak, T.
Right arrow Articles by Weiss, J. P.

 Previous Article  |  Next Article 

Infection and Immunity, May 2008, p. 2169-2176, Vol. 76, No. 5
0019-9567/08/$08.00+0     doi:10.1128/IAI.01705-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Wall Teichoic Acid Deficiency in Staphylococcus aureus Confers Selective Resistance to Mammalian Group IIA Phospholipase A2 and Human β-Defensin 3{triangledown}

Tomaz Koprivnjak,1,3* Christopher Weidenmaier,5 Andreas Peschel,6 and Jerrold P. Weiss1,2,3,4

Inflammation Program,1 Departments of Microbiology,2 Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa,3 Veterans' Administration Medical Center, Iowa City, Iowa 52242,4 Channing Laboratory, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts 02134,5 Cellular and Molecular Microbiology, Department of Medical Microbiology and Hygiene, University Hospitals Tübingen, 72076 Tübingen, Germany6

Received 20 December 2007/ Returned for modification 30 January 2008/ Accepted 2 March 2008

Wall teichoic acids (WTAs) and membrane lipoteichoic acids (LTAs) are the major polyanionic polymers in the envelope of Staphylococcus aureus. WTAs in S. aureus play an important role in bacteriophage attachment and bacterial adherence to certain host cells, suggesting that WTAs are exposed on the cell surface and could also provide necessary binding sites for cationic antimicrobial peptides and proteins (CAMPs). Highly cationic mammalian group IIA phospholipase A2 (gIIA PLA2) kills S. aureus at nanomolar concentrations by an action(s) that depends on initial electrostatic interactions, cell wall penetration, membrane phospholipid (PL) degradation, and activation of autolysins. A tagO mutant of S. aureus that lacks WTA is up to 100-fold more resistant to PL degradation and killing by gIIA PLA2 and CAMP human β-defensin 3 (HBD-3) but has the sensitivity of the wild type (wt) to other CAMPs, such as Magainin II amide, hNP1-3, LL-37, and lactoferrin. In contrast, there is little or no difference in either gIIA PLA2 activity toward cell wall-depleted protoplasts of the wt and tagO strains of S. aureus or in binding of gIIA PLA2 to wt and tagO strains. Scanning and transmission electron microscopy reveal increased surface protrusions in the S. aureus tagO mutant that might account for reduced activity of bound gIIA PLA2 and HBD-3 toward the tagO mutant. In summary, the absence of WTA in S. aureus causes a selective increase in bacterial resistance to gIIA PLA2 and HBD-3, the former apparently by reducing access and/or activity of bound antibacterial enzyme to the bacterial membrane.


* Corresponding author. Mailing address: Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, 2501 Crosspark Road, MTF D109, Coralville, IA 52241. Phone: (319) 335-4582. Fax: (319) 335-4194. E-mail: tomaz-koprivnjak{at}uiowa.edu

{triangledown} Published ahead of print on 17 March 2008.

Editor: J. B. Bliska


Infection and Immunity, May 2008, p. 2169-2176, Vol. 76, No. 5
0019-9567/08/$08.00+0     doi:10.1128/IAI.01705-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kohler, T., Weidenmaier, C., Peschel, A. (2009). Wall Teichoic Acid Protects Staphylococcus aureus against Antimicrobial Fatty Acids from Human Skin. J. Bacteriol. 191: 4482-4484 [Abstract] [Full Text]  
  • Senyurek, I., Paulmann, M., Sinnberg, T., Kalbacher, H., Deeg, M., Gutsmann, T., Hermes, M., Kohler, T., Gotz, F., Wolz, C., Peschel, A., Schittek, B. (2009). Dermcidin-Derived Peptides Show a Different Mode of Action than the Cathelicidin LL-37 against Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 2499-2509 [Abstract] [Full Text]